Aster Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Buy
2,801
+2,760
+6,732% +$460K 0.09% 286
2026
Q1
$10.8K Sell
41
-600
-94% -$151K ﹤0.01% 618
2025
Q4
$182K Sell
641
-2,338
-78% -$731K 0.08% 238
2025
Q3
$920K Buy
2,979
+2,712
+1,016% +$850K 0.46% 45
2025
Q2
$83.9K Sell
267
-1,701
-86% -$491K 0.02% 533
2025
Q1
$536K Buy
+1,968
New +$533K 0.1% 275

Other funds holding PODD

Aster Capital Management's PODD Position: Q2 2026 in Review

Aster Capital Management increased its Insulet (PODD) stake by 6,732% in Q2 2026, buying an estimated $460K and bringing the position to 2,801 shares worth $426K. The position accounts for 0.09% of the portfolio, ranked #286.

Aster Capital Management first reported a position in PODD in Q1 2025 and has held it in 6 quarters since. The position peaked at $920K in Q3 2025. 730 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Aster Capital Management held 2,801 shares of Insulet worth $426K as of Q2 2026.
  • Aster Capital Management bought 2,760 Insulet shares in Q2 2026, an estimated $460K.
  • Insulet made up 0.09% of Aster Capital Management's portfolio in Q2 2026, its #286 holding.
  • Aster Capital Management first reported a position in Insulet in Q1 2025 and has held it in 6 quarters since.
  • Aster Capital Management's Insulet position peaked at $920K in Q3 2025.
  • 730 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.